Yen-lin Peng

Title: Yen-lin Peng: Innovator in Colorectal Cancer Detection

Introduction

Yen-lin Peng is a notable inventor based in Mission Viejo, CA (US). He has made significant contributions to the field of cancer detection, particularly in colorectal cancer. With a total of 2 patents, his work focuses on improving diagnostic methods and treatment decisions.

Latest Patents

Yen-lin Peng's latest patents include innovative approaches to cancer detection. One of his patents, titled "Methylated markers for colorectal cancer," discloses a combination of genomic sequences whose methylation patterns are useful for the improved detection and differentiation between colorectal neoplasms. This patent also includes methods, nucleic acids, and kits for detecting or differentiating between these neoplasms. Another significant patent is "Discriminating BRAF mutations," which provides methods for detecting and discriminating BRAF V600 mutations. This patent is crucial for diagnosis, prognosis, management, and treatment decisions related to BRAF V600 mutation-related diseases or conditions.

Career Highlights

Throughout his career, Yen-lin Peng has worked with prominent companies in the healthcare sector. He has been associated with Quest Diagnostics Investments, Inc. and Clinical Genomics Pty. Ltd. His work in these organizations has furthered advancements in genomic research and cancer diagnostics.

Collaborations

Yen-lin Peng has collaborated with several professionals in his field, including Amber C. Donahue and Susanne Kartin Pedersen. These collaborations have contributed to the development of innovative solutions in cancer detection and treatment.

Conclusion

Yen-lin Peng's contributions to colorectal cancer detection through his patents and collaborations highlight his role as an innovator in the medical field. His work continues to impact the way colorectal neoplasms are diagnosed and treated.